#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16104	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1998	797.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1370	1370	C	977	C,A	906,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16104	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1998	797.6	0	HET	.	.	.	C226T,G	.	226	226	C	412	412	C	882	C,T,G	629,177,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29474	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3556	826.6	0	.	n	.	0	T695C	SNP	695	695	T	995	995	C	947	C	875	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29474	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3556	826.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	1938	1938	G	979	G,A	692,210	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29474	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3556	826.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2271	2271	C	939	C,T	869,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29474	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3556	826.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2345	2345	A	874	A	824	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29474	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3556	826.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2897	2897	C	952	C	886	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2218	folP	855	855	100.0	folP.l6.c4.ctg.1	1486	148.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1025	1027	AGC	232;230;226	A;G;C	214;211;211	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5640	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3297	170.6	1	SNP	p	S91F	1	.	.	271	273	TTC	543	545	TTC	188;187;189	T;T;C	180;179;178	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5640	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3297	170.6	1	SNP	p	G95N	0	.	.	283	285	GGC	555	557	GGC	188;190;189	G;G;C	174;174;174	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5640	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3297	170.6	1	SNP	p	D95G	1	.	.	283	285	GGC	555	557	GGC	188;190;189	G;G;C	174;174;174	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1768	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1409	125.4	1	SNP	p	G45D	0	.	.	133	135	GGC	545	547	GGC	247;247;249	G;G;C,A	229;229;226,2	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	878	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1047	83.4	0	.	n	.	0	A197.	DEL	197	197	A	609	609	A	205	A	188	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5626	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2821	198.6	1	SNP	p	D86N	0	.	.	256	258	GAC	515	517	GAC	237;240;241	G;A;C	219;220;225	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5626	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2821	198.6	1	SNP	p	R87I	0	.	.	259	261	CGT	518	520	CGT	240;241;241	C,A;G;T	220,2;221;221	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5626	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2821	198.6	1	SNP	p	S87R	1	.	.	259	261	CGT	518	520	CGT	240;241;241	C,A;G;T	220,2;221;221	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5626	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2821	198.6	1	SNP	p	R87W	0	.	.	259	261	CGT	518	520	CGT	240;241;241	C,A;G;T	220,2;221;221	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5626	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2821	198.6	1	SNP	p	S88P	0	.	.	262	264	TCC	521	523	TCC	240;239;240	T;C;C,T	218;220;221,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4578	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2600	175.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1499	1501	GGC	231;225;222	G;G;C	211;206;202	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2350	179.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1236	1238	GCA	239;236;234	G;C;A,C	222;216;218,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2350	179.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1239	1241	ATC	233;233;236	A,G;T;C,G	216,1;217;218,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2350	179.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1251	1253	GTG	238;238;237	G,A;T,C;G,C	216,1;214,1;216,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2350	179.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1251	1253	GTG	238;238;237	G,A;T,C;G,C	216,1;214,1;216,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2350	179.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1755	1757	ACC	216;216;215	A;C;C	196;198;196	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2350	179.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1809	1811	GCG	195;192;197	G;C;G	178;160;176	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2350	179.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1809	1811	GCG	195;192;197	G;C;G	178;160;176	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2350	179.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1932	1934	AGC	202;202;200	A;G;C	186;183;183	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2350	179.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1941	1943	GGC	200;199;198	G;G;C	181;181;179	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4248	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2350	179.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1959	1961	CCG	170;173;178	C,G;C,G;G,C	119,6;122,1;131,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6090	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3193	190.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1713	1715	CCG	205;207;209	C;C,T;G	173;185,1;181	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2268	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1790	126.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	545	545	C	184	C	170	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1496	196.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	419	421	GAA	262;263;261	G;A;A	244;245;244	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1496	196.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	707	709	GAT	237;240;241	G,A;A;T	215,1;215;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1496	196.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	830	832	TCA	213;213;211	T,G;C;A	197,1;199;195	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1496	196.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	959	961	GTC	263;261;258	G;T;C	249;248;244	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1496	196.4	0	.	p	.	0	F222S	NONSYN	664	666	TTT	971	973	TCT	269;266;268	T;C;T	256;253;253	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1496	196.4	0	.	p	.	0	A272V	NONSYN	814	816	GCG	1121	1123	GTG	269;268;268	G;T,C;G,T	248;246,1;248,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1496	196.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1289	1291	GCA	230;230;232	G;C;A	211;208;211	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1496	196.4	1	SNP	p	G120K	1	.	.	358	360	AAG	665	667	AAG	229;230;230	A;A;G	216;216;214	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1496	196.4	1	SNP	p	A121D	1	.	.	361	363	GAC	668	670	GAC	229;230;232	G,A;A;C	214,1;215;218	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2952	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1496	196.4	1	SNP	p	D121N	0	.	.	361	363	GAC	668	670	GAC	229;230;232	G,A;A;C	214,1;215;218	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11480	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4612	247.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1348	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	988	135.4	1	SNP	p	V57M	1	.	.	169	171	ATG	503	505	ATG	268;269;271	A;T,C;G,C	247;250,1;251,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
